Jonathan is a seasoned leader with a proven track record in driving sales, product growth and market strategy across diverse sectors within the Clinical trials space, including Medical Devices, Biostatistics, and Contract Research Organizations (CROs). As Senior Manager, Product Growth and Market Strategy at 4G Clinical, he leverages his extensive background in sales and operations to identify and capitalize on market opportunities within the Randomization and Trial Supply Management (RTSM) space. Jonathan’s strategic vision and data-driven approach are instrumental in accelerating product adoption and expanding market share, ultimately contributing to the advancement of clinical research and the development of innovative medical solutions.

Gemma Lofts is an accomplished Clinical Supply Chain professional with over 12 years of experience working in oncology, respiratory, cell and gene and controlled drugs. Gemma is currently the Director of Clinical Supply Chain at Bicycle Therapeutics, where she has set up end-to-end processes to support the expansion of their oncology platform from phase 1 into global phase 2/3 registrational trials. As a small biotech moving to mid-size with a fully outsourced model, this included the selection and set up of new vendors and procedures to ensure best practice and compliance.

Benoit Cuyvers is the Upstream AI (Artificial Intelligence) Product Manager for Clario, recently joining the team from the ArtiQ acquisition. (Leuven, Belgium). The acquisition advances our respiratory solutions portfolio, combining Clario’s deep scientific expertise with ArtiQ’s innovative artificial intelligence capabilities. Benoit led the efforts on the ArtiQ AI-enabled Risk Based Monitoring system, from concept to solution and will continue these endeavors in his role at Clario. With his background in Bioscience Engineering and his past experience as a digital health expert at Siemens, Benoit is able to apply learnings from other medical and technical fields to the field of AI in respiratory research & medicine.

Martin is a prominent leader in hospitality technology with extensive expertise across strategy, operations, digital solutions, business partnerships, program management, infrastructure, cybersecurity, and application development.

His career highlights include technology roles at InterContinental, Four Seasons, Radisson, and most recently Marriott International where he spent the last 26 years leading the discipline for Asia Pacific including oversight of the successful integration of Starwood Hotels & Resorts and The Ritz-Carlton.

Recently, he founded Bookallil Advisory, a consulting firm based in Hong Kong, offering technology advisory services to the hospitality sector.

Matthew Albert is Head of Translational Sciences and Early Clinical Development at Octant Biosciences, using cellular intelligence and high throughput approaches to develop corrector therapeutics. Prior roles include: Chief Translational Officer at Human Immunology Biosciences (HI-Bio 2018-2019); and Sr Vice President of Biology and Translational Genetics at insitro, a biotechnology company committed to leveraging biomolecular data at scale for purposes of drug development (2019-2021). He was a Principal Scientist at Genentech, working in the Department of Cancer Immunology where he led a team of immunologists, geneticists, microbiome scientists and mathematicians with the aim to derive new insight from human subject studies and real world data (2015-2019). His prior academic career included INSERM director of research and full professor working at Institut Pasteur, where he headed the Director of the Department of Immunology (2010 – 2015); and was the Founding Director of The Center for Human Immunology at Institut Pasteur (2007 – 2015).

Matthew received his M.D. at Cornell University Medical College and his Ph.D. in Immunology at The Rockefeller University. He trained in Clinical Pathology at The New York Presbyterian Hospital and was a Clinical Scholar at The Rockefeller University Hospital. His basic science and clinical research achievements include the characterization of the cellular and molecular mechanisms underlying the cross-priming of tumor and viral-specific cytolytic T lymphocytes (CTLs). He has also made impactful contributions in the fields of tumor immunity in patients with bladder cancer; and helped to define the complex role of type I IFNs in HCV disease pathogenesis.

He has successfully launched a commercialized biomarker assay for agonist and antagonist forms of CXC10, in partnership with Myriad-RBM; and established point-of-care tests for managing patients with Hepatitis C with Epistem, Inc. Other notable achievements include coordination of multiple international projects, including the The Milieu Intérieur Project: Defining the genetic and environmental determinants of immune phenotype variance – establishing a path towards personalized medicine.

Jackie Park is the Managing Editor of GlobalData’s energy publications, Power Technology and Future Power Technology.

Her coverage expands across the sector, from renewables and energy storage to EVs and grids. Jackie has also worked for NBC affiliate WRAL-TV in North Carolina, US and The JoongAng in South Korea. She graduated with a degree in public policy with a concentration in policy journalism at Duke University and obtained her masters in global politics and communications at the University of Helsinki

Luca Nuvolin is a seasoned industry expert with nearly 30 years of experience at leading companies such as BNP Paribas, DLL (including their previously owned mobility solutions business, Athlon) and most recently at PEAC Solutions.

Throughout his career, he has held key management roles in Italy and Southern Europe, with a focus on vendor finance. Luca has successfully launched three captives and two rental companies, consistently driving business growth and innovation. His leadership at Athlon, where he significantly advanced the car rental sector, exemplifies his ability to develop niche vendor businesses from the ground up.

Luca holds a degree in Business Administration.

Mike is a geoscientist with 13 years’ experience in mineral exploration and mining development projects in Australia and Africa with MMG, OZ Minerals and BHP (from 2023). He has broad experience in copper mineral systems, from early-stage exploration through to resource modelling, with a particular interest in sediment-hosted copper systems. He is passionate about working with people to drive successful mineral exploration and believes the outcome of discovery will follow.